Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.428.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.459NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.415.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.243.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.98NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.566NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.480NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.46NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.530NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.17.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.570NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.633NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.136NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAYNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAENChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.467NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.484NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.476NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.404NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
CV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.38.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N/ANChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.38.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N/ANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.73NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BR.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.75.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAKNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.596.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.473NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.595.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
BA.2.76.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.38.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used